Psychiatr. pro Praxi, 2001; 4: 169-172

Epileptogenní potenciál psychofarmak

prof. MUDr. Jaromír ©vestka DrSc
Psychiatrická klinika LF MU a FN Brno

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©vestka J. Epileptogenní potenciál psychofarmak. Psychiatr. praxi. 2001;2(4):169-172.

Úvod

Větąina psychofarmak v terapeutických dávkách vyvolává epileptické záchvaty u méně neľ 0,4 % léčených osob bez epileptického onemocnění. Výjimky tvoří z antidepresiv maprotilin, bupropion, clomipramin, vyąąí dávky imipraminu, mianserinu, z antipsychotik clozapin a zotepin a z jiných lithium.

Download citation

References

  1. Bazire, S. (2000): Psychotropic drug directory. Quay Books, Dinton, 185-187.
  2. Bell, A. J., Cole, A., Eccleston, D. et al. (1993): Lithium neurotoxicity at normal therapeutic level. Br. J. Psychiatry, 162: 688-692. Go to original source... Go to PubMed...
  3. Favale, E., Rubino, V., Mainardi, P., Lunardi, G., et al. (1995): Anticonvulsant effect of fluoxetine in humans. Neurology, 45: 1926-1927. Go to original source... Go to PubMed...
  4. Frommer, D. A., Kulig, K. W., Marx, J. A, et al. (1987): Tricyclic antidepressant overdose. A review. JAMA, 257: 521-526. Go to original source... Go to PubMed...
  5. Hersdorfer, D. C., Hauser, W. A., Annegers, J. F., Cascino, G. (2000): Major depression is a risk factor for seizures in older adults. Ann. Neurol., 47: 246-249. Go to original source... Go to PubMed...
  6. Jabbari, B., Bryan, G. E., Marsh, E. E. et al. (1985): Incidence of seizures with tricyclic and tetracyclic antidepressants. Arch. Neurol., 42: 480-481. Go to original source... Go to PubMed...
  7. Lambert, M. V., Robertson, M. M. (1999): Depression in epilepsy: Etiology, phenomenology, and treatment. Epilepsia, 40 (Suppl. 10): 21-47. Go to original source... Go to PubMed...
  8. Ojemann, L. M., Baugh-Bookman, B. S., Dudley, D. L. (1987): Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology, 37: 1525-1527. Go to original source... Go to PubMed...
  9. Pisani, F., Spina, E., Oteri, G. (1999): Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice. Epilepsia, 40 (Suppl. 10): 48-56. Go to original source... Go to PubMed...
  10. Preskorn, S. H., Fast, G. A. (1992): Tricyclic antidepressant-induced seizures and plasma drug concentration. J. Clin. Psychiatry, 53: 160-162.
  11. Rosenstein, D. L., Nelson, J. C., Jacobs, S. C. (1993): Seizures associated with antidepressants. A review. J. Clin. Psychiatry, 54: 289-299.
  12. Schatzberg, A. F., Nemeroff, C. B. (2001): Essentials of clinical psychopharmacology. American Psychiatric Publishing, Washington, 780 pp.
  13. Schou, M., Amdisen, A., Trap-Jensen, J. (1968): Lithium poisoning. Am. J. Psychiatry, 125: 520-527. Go to original source... Go to PubMed...
  14. ©vestka, J. (1998): Clozapin - prototyp antipsychotik nové generace. MaxdorfJesenius, Praha: 95-98.
  15. ©vestka, J. (2001): Zotepin - atypicky typické nebo netypicky atypické antipsychotikum? Psychiatrie, 5: 107-118.
  16. Wroblewski, B. A., McColgan, K., Smith, K. et al. (1990): The incidence of seizures during tricyclic antidepressant treatment in a brain-injured populations. J. Clin. Psychopharmacol, 10: 124-128. Go to original source... Go to PubMed...
  17. Wolfson, M., Einat, H., Bersudsky, Y., Berkin, V., Belmaker, R. H., Hertz, L. (2000): Nordidemnim potently inhibits inositol uptake in cultured astrocytes and dose-dependently augments lithium´s proconvulsant effect in vivo. J. Neurosci. Res., 60: 116-121. Go to original source... Go to PubMed...
  18. Zaccara, G., Muscas, G. C., Messori, A. (1990): Clinical features, pathogenesis and management of drug-induced seizures. Drug Safety, 5: 2-43. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.